Proposed Data Collections Submitted for Public Comment and Recommendations, 80507-80508 [2010-32078]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 245 / Wednesday, December 22, 2010 / Notices
Dated: December 16, 2010.
Catina Conner,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2010–32076 Filed 12–21–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–11–11BF]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
srobinson on DSKHWCL6B1PROD with NOTICES
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instrument, call 404–639–5960 and send
comments to Carol E. Walker, Acting
CDC Reports Clearance Officer, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30333; or send an e-mail to
omb@cdc.gov.
Comments are invited on (a) whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have a
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Contact Investigation Outcome
Reporting Forms—New—National
Center for Emerging, Zoonotic and
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
VerDate Mar<15>2010
20:24 Dec 21, 2010
Jkt 223001
Background and Brief Description
CDC proposes to collect passengerlevel, epidemiologic, demographic, and
health status data from State/local
Health Departments and maritime
operators at the conclusion of contact
investigations of individuals believed to
have been exposed to a communicable
disease during travel. The information
requested by CDC would be obtained by
the health departments or maritime
operators while conducting the contact
investigation according to their
established policies and procedures,
and would be reported to CDC on a
voluntary basis. This information will
assist CDC in fulfilling its regulatory
responsibility to prevent the
importation of communicable diseases
from foreign countries (42 CFR part 71)
and interstate control of communicable
diseases in humans (42 CFR part 70). To
perform these tasks in a streamlined
manner and ensure that all relevant
information is collected in the most
efficient and timely manner possible,
Quarantine Stations use a number of
forms: Contact Investigation Outcome
Reporting Forms: (1) Optional TB Air/
Land Contact Investigation Outcome
Reporting, (2) Optional Measles,
Mumps, or Rubella Air/Land Contact
Investigation Outcome Reporting, (3)
Optional General Air/Land Contact
Investigation Outcome Reporting Form,
(4) Optional TB Maritime Contact
Investigation Outcome Reporting Form,
(5) Optional Measles, Mumps or Rubella
Maritime Contact Investigation Outcome
Reporting Form, (6) Optional General
Maritime Contact Investigation Outcome
Reporting Form.
Section 361 of the Public Health
Service (PHS) Act (42 USC 264)
authorizes the Secretary of Health and
Human Services to make and enforce
regulations necessary to prevent the
introduction, transmission or spread of
communicable diseases from foreign
countries into the United States. The
regulations that implement this law, 42
CFR parts 70 and 71, require
conveyances to report an ‘‘ill person’’ or
any death onboard to authorized
quarantine officers and other personnel
to inspect and undertake necessary
control measures with respect to
conveyances (e.g., airplanes, cruise
ships), persons, and shipments of
animals and etiologic agents in order to
protect the public health. The
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
80507
notification is made possible by
contacting individuals who may have
been exposed to a communicable
disease during travel and their contacts,
and investigating this exposure so that
the necessary medical or public health
interventions can be implemented.
CDC provides state and local health
departments and maritime conveyance
operators with information to notify and
contact individuals and further
investigate this exposure by contacting
others who may have been potentially
exposed to disease. However, there
currently is no standardized tool or form
to collect pertinent information
regarding the outcome of such
investigations.
To address the need to inform CDC of
additional actions that may be needed to
further protect public health based on
the outcome of the contact
investigations, CDC has developed six
forms to assist health departments and
maritime conveyance operators in
reporting back to CDC. The forms are
specific to the nature of the
investigation; Tuberculosis (TB),
Measles, Mumps, and Rubella or the
General forms specific to other diseases
of public health concern. The purpose
of the forms is the same: To collect
information to help CDC quarantine
officials to fully understand the extent
of disease spread and transmission
during travel and to inform the
development and or refinement of
investigative protocols, aimed at
reducing the spread of communicable
disease.
All six forms collect the following
categories of information: Heath status
of traveler, clinical history including
diagnosis, and interventions related to
exposure.
Respondents are state and local health
departments and maritime conveyance
operators. Respondents will use these
standardized forms to submit data to
CDC for each individual contacted via a
secure means of their choice, e.g., Webbased application, fax or e-mail.
The estimated total burden on the
public, included in the chart below, can
vary a great deal depending on the
number of flights and the number of
individuals identified as contacts that
are assigned to a given health
jurisdiction in the U.S. There is no cost
to respondents other than their time.
E:\FR\FM\22DEN1.SGM
22DEN1
80508
Federal Register / Vol. 75, No. 245 / Wednesday, December 22, 2010 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden/
response
(in hours)
Number of
responses/
respondent
Total burden
hours
Respondents
Forms
State/Local health department staff ..
Optional TB Air/Land Contact Investigation Outcome Reporting Form.
Optional Measles, Mumps or Rubella Air/Land Contact Investigation
Outcome Reporting Form.
Optional General Air/Land Contact
Investigation Outcome Reporting
Form.
Optional TB Maritime Contact Investigation Outcome Reporting Form.
Optional Measles, Mumps or Rubella Maritime Contact Investigation
Outcome Reporting Form.
Optional General Maritime Contact
Maritime Operators Investigation
Outcome Reporting Form.
2154
1
5/60
180
367
1
5/60
31
456
1
5/60
38
190
1
5/60
16
140
1
5/60
12
40
1
5/60
3
...........................................................
........................
........................
........................
280
State/Local health department staff ..
State/Local health department staff ..
Maritime Operators ...........................
Maritime Operators ...........................
Maritime Operators ...........................
Total ...........................................
Dated: December 16, 2010.
Catina Conner,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2010–32078 Filed 12–21–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
srobinson on DSKHWCL6B1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Enabling Bioanalytical and Imaging
Technologies.
Date: December 29, 2010.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call.)
VerDate Mar<15>2010
20:24 Dec 21, 2010
Jkt 223001
Contact Person: Allen Richon, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6181,
MSC 7892, Bethesda, MD 20892. 301–435–
2902. allen.richon@nih.hhs.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Vascular and Hematology SEP.
Date: January 10–11, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Bukhtiar H. Shah, DVM,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4120,
MSC 7802, Bethesda, MD 20892. (301) 301
806–7314. shahb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Diabetes, Obesity and Nutrition.
Date: January 10, 2011.
Time: 1p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: John Bleasdale, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6170,
MSC 7892, Bethesda, MD 20892. 301–435–
4514. bleasdaleje@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Devices for the NICU. RFA HD10–
012 and 013.
Date: January 21, 2011.
Time: 11 a.m. to 7 p.m.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda North Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: John Firrell, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213,
MSC 7854, Bethesda, MD 20892. 301–435–
2598. firrellj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 15, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–32100 Filed 12–21–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\22DEN1.SGM
22DEN1
]]>Agencies
[Federal Register Volume 75, Number 245 (Wednesday, December 22, 2010)]
[Notices]
[Pages 80507-80508]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32078]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-11-11BF]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instrument, call 404-639-5960 and
send comments to Carol E. Walker, Acting CDC Reports Clearance Officer,
1600 Clifton Road NE., MS-D74, Atlanta, Georgia 30333; or send an e-
mail to omb@cdc.gov.
Comments are invited on (a) whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have a practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Contact Investigation Outcome Reporting Forms--New--National Center
for Emerging, Zoonotic and Infectious Diseases (NCEZID), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC proposes to collect passenger-level, epidemiologic,
demographic, and health status data from State/local Health Departments
and maritime operators at the conclusion of contact investigations of
individuals believed to have been exposed to a communicable disease
during travel. The information requested by CDC would be obtained by
the health departments or maritime operators while conducting the
contact investigation according to their established policies and
procedures, and would be reported to CDC on a voluntary basis. This
information will assist CDC in fulfilling its regulatory responsibility
to prevent the importation of communicable diseases from foreign
countries (42 CFR part 71) and interstate control of communicable
diseases in humans (42 CFR part 70). To perform these tasks in a
streamlined manner and ensure that all relevant information is
collected in the most efficient and timely manner possible, Quarantine
Stations use a number of forms: Contact Investigation Outcome Reporting
Forms: (1) Optional TB Air/Land Contact Investigation Outcome
Reporting, (2) Optional Measles, Mumps, or Rubella Air/Land Contact
Investigation Outcome Reporting, (3) Optional General Air/Land Contact
Investigation Outcome Reporting Form, (4) Optional TB Maritime Contact
Investigation Outcome Reporting Form, (5) Optional Measles, Mumps or
Rubella Maritime Contact Investigation Outcome Reporting Form, (6)
Optional General Maritime Contact Investigation Outcome Reporting Form.
Section 361 of the Public Health Service (PHS) Act (42 USC 264)
authorizes the Secretary of Health and Human Services to make and
enforce regulations necessary to prevent the introduction, transmission
or spread of communicable diseases from foreign countries into the
United States. The regulations that implement this law, 42 CFR parts 70
and 71, require conveyances to report an ``ill person'' or any death
onboard to authorized quarantine officers and other personnel to
inspect and undertake necessary control measures with respect to
conveyances (e.g., airplanes, cruise ships), persons, and shipments of
animals and etiologic agents in order to protect the public health. The
notification is made possible by contacting individuals who may have
been exposed to a communicable disease during travel and their
contacts, and investigating this exposure so that the necessary medical
or public health interventions can be implemented.
CDC provides state and local health departments and maritime
conveyance operators with information to notify and contact individuals
and further investigate this exposure by contacting others who may have
been potentially exposed to disease. However, there currently is no
standardized tool or form to collect pertinent information regarding
the outcome of such investigations.
To address the need to inform CDC of additional actions that may be
needed to further protect public health based on the outcome of the
contact investigations, CDC has developed six forms to assist health
departments and maritime conveyance operators in reporting back to CDC.
The forms are specific to the nature of the investigation; Tuberculosis
(TB), Measles, Mumps, and Rubella or the General forms specific to
other diseases of public health concern. The purpose of the forms is
the same: To collect information to help CDC quarantine officials to
fully understand the extent of disease spread and transmission during
travel and to inform the development and or refinement of investigative
protocols, aimed at reducing the spread of communicable disease.
All six forms collect the following categories of information:
Heath status of traveler, clinical history including diagnosis, and
interventions related to exposure.
Respondents are state and local health departments and maritime
conveyance operators. Respondents will use these standardized forms to
submit data to CDC for each individual contacted via a secure means of
their choice, e.g., Web-based application, fax or e-mail.
The estimated total burden on the public, included in the chart
below, can vary a great deal depending on the number of flights and the
number of individuals identified as contacts that are assigned to a
given health jurisdiction in the U.S. There is no cost to respondents
other than their time.
[[Page 80508]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden/ Total burden
Respondents Forms respondents responses/ response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
State/Local health department Optional TB Air/ 2154 1 5/60 180
staff. Land Contact
Investigation
Outcome
Reporting Form.
State/Local health department Optional 367 1 5/60 31
staff. Measles, Mumps
or Rubella Air/
Land Contact
Investigation
Outcome
Reporting Form.
State/Local health department Optional General 456 1 5/60 38
staff. Air/Land
Contact
Investigation
Outcome
Reporting Form.
Maritime Operators............ Optional TB 190 1 5/60 16
Maritime
Contact
Investigation
Outcome
Reporting Form.
Maritime Operators............ Optional 140 1 5/60 12
Measles, Mumps
or Rubella
Maritime
Contact
Investigation
Outcome
Reporting Form.
Maritime Operators............ Optional General 40 1 5/60 3
Maritime
Contact
Maritime
Operators
Investigation
Outcome
Reporting Form.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 280
----------------------------------------------------------------------------------------------------------------
Dated: December 16, 2010.
Catina Conner,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2010-32078 Filed 12-21-10; 8:45 am]
BILLING CODE 4163-18-P
